Unknown

Dataset Information

0

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.


ABSTRACT: Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.

SUBMITTER: Sherman MM 

PROVIDER: S-EPMC4771085 | biostudies-other | 2016 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.

Sherman Matthew M MM   Ungureanu Sinziana S   Rey Jose A JA  

P & T : a peer-reviewed journal for formulary management 20160301 3


Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults. ...[more]

Similar Datasets

| S-EPMC3586099 | biostudies-literature
| S-EPMC5998459 | biostudies-other
| S-EPMC5850123 | biostudies-literature
| S-EPMC3836105 | biostudies-literature
| S-EPMC7532917 | biostudies-literature
| S-EPMC8111570 | biostudies-literature
| S-EPMC3795584 | biostudies-literature
| S-EPMC5299461 | biostudies-literature
| S-EPMC4174046 | biostudies-other
| S-EPMC3739931 | biostudies-literature